Patients with eyebrow thinning graded as level 1 or 2 according to the Allergan Global Eyebrow Assessment (GEBA) scale eyebrow enhancement
Conditions
Interventions
Patients underwent ten sessions of 675-nm laser treatment on one randomly selected eyebrow (the same side at every visit), administered twice weekly for five consecutive weeks.,No treatment
Experimental Device,No Intervention No treatment
675- Laser,No treatment
Sponsors
Woraphong Manuskiatti
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Male or female patients 2.Age 20 - 60 years old 3.Patients with eyebrow thinning graded as level 1 or 2 according to the Allergan Global Eyebrow Assessment (GEBA) scale
Exclusion criteria
Exclusion criteria: 1.Patients with a history of hair disorders other than androgenetic alopecia. 2.Patients with pregnancy or breastfeeding 3.Patients with a history of collagen disorders such as Cushing syndrome or Ehlers-Danlos syndrome. 4.Patients who have previously undergone laser therapy or radiotherapy on the eyebrows. 5.Patients with any scars on the eyebrows. 6.Patients with dermatitis, wounds, or skin infections in the treatment area. 7.Patients with a history of thyroid disease or liver disease. 8.Patients with a history of cancer, currently receiving cancer treatment, or with skin cancer in the treatment area. 9.Patients with a history of immunodeficiency, including HIV infection or AIDS. 10.Patients with a history of abnormal photosensitivity. 11.Patients who have received topical and/or oral medications, platelet-rich plasma injections, or alternative treatments deemed by the investigator to potentially affect the study within 3 months before enrollment. 12.Patients with a history of hormone therapy or contraceptive use, both oral and injectable. 13.Patients with a history of psychiatric disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair count 1st treatment, 5th treatment, 1 month, 3 months, 6 months Trichoscan,Hair Density 1st treatment, 5th treatment, 1 month, 3 months, 6 months Trichoscan,Hair Thickness 1st treatment, 5th treatment, 1 month, 3 months, 6 months Trichoscan | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score 1st-10th treatment Visual Analog Scale, Safety 1st-10th treatment Adverse event | — |
Countries
Thailand
Contacts
Public ContactWoraphong Manuskiatti
Faculty of Medicine Siriraj Hospital
Outcome results
None listed